Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening.
Dighe, S.N., Deora, G.S., De la Mora, E., Nachon, F., Chan, S., Parat, M.O., Brazzolotto, X., Ross, B.P.(2016) J Med Chem 59: 7683-7689
- PubMed: 27405689 
- DOI: https://doi.org/10.1021/acs.jmedchem.6b00356
- Primary Citation of Related Structures:  
5K5E - PubMed Abstract: 
Structure-based virtual screening of two libraries containing 567 981 molecules was used to discover novel, selective BuChE inhibitors, which are potentially superior symptomatic treatments in late-stage Alzheimer's disease. Compound 16 was identified as a highly selective submicromolar inhibitor of BuChE (huBuChE IC50 = 0.443 μM) with high permeability in the PAMPA-BBB model. The X-ray crystal structure of huBuChE in complex with 16 revealed the atomic-level interactions and offers opportunities for further development of the series.
Organizational Affiliation: 
School of Pharmacy, The University of Queensland , Brisbane, Queensland 4072, Australia.